GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Total Operating Expense

Neurogene (Neurogene) Total Operating Expense : $46.59 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Neurogene Total Operating Expense?

Neurogene's Total Operating Expense for the three months ended in Mar. 2024 was $18.78 Mil. Neurogene's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was $46.59 Mil.

Neurogene Total Operating Expense Historical Data

The historical data trend for Neurogene's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Total Operating Expense Chart

Neurogene Annual Data
Trend Dec21 Dec22 Dec23
Total Operating Expense
50.53 56.52 55.58

Neurogene Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Operating Expense Get a 7-Day Free Trial 13.04 12.60 15.22 - 18.78

Neurogene Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $46.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurogene Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Neurogene's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurogene (Neurogene) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Total Operating Expense
Comparable Companies
Traded in Other Exchanges
N/A
Address
535 W 24th Street, 5th Floor, New York, NY, USA, 10011
Website
https://www.neurogene.com
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines

From GuruFocus

Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million

By Business Wire • 12-19-2023

Neurogene Announces Business Update and 2024 Outlook

By Business Wire • 01-05-2024